A Case of Isolated CNS Relapse in a CML Patient on Chronic Phase
Laurence Adlai B. Morillo, Flordeluna Zapata-Mesina, Ma Rosario Irene D. Castillo
International Blood Research & Reviews · pp. 1–8 · Published 1 Sep 2015
10.9734/IBRR/2015/17731Abstract
We report a patient who achieved hematologic response with Imatinib mesylate and is in chronic phase, but after several years developed neurologic symptoms and was eventually documented to have an isolated CNS relapse. The patient was treated with intrathecal chemotherapy to clear the spinal fluid of the leukemia cells. Imatinib mesylate (STI-571) is a potent and selective inhibitor of BCR-ABL tyrosine kinase and has emerged as a treatment of choice in chronic myeloid leukaemia. However because of poor penetration of the drug to the blood-brain barrier of the central nervous system (CNS), then the CNS acts as a sanctuary site for malignant cells.
References (22)
- 1 Chronic myelogenous leukemia: mechanisms underlying disease progression [DOI]
- 2 Chronic myeloid leukemia in Asia [DOI]
- 3 Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
- 4 The Biology of CML Blast Crisis [DOI]
- 5 Extramedullary blast crisis in chronic myeloid leukemia [DOI]
- 6 Isolated central nervous system blast crisis in chronic myeloid leukemia [DOI]
- 7 Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report [DOI]
- 8 Isolated Central Nervous System Relapse in Lymphoid Blast Crisis Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Patients on Imatinib Therapy [DOI]
- 9 CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid [DOI]
- 10 Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy [DOI]
- 11 Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate [DOI]
- 12 Central Nervous System Blast Crisis in Chronic Myeloid Leukemia on Imatinib Mesylate Therapy: Report of Two Cases [DOI]
- 13 Dasatinib Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for an Isolated Central Nervous System Blast Crisis in Chronic Myelogenous Leukemia [DOI]
- 14 Isolated Blast Crisis in CNS in a Patient With Chronic Myelogenous Leukemia Maintaining Major Cytogenetic Response After Imatinib [DOI]
- 15 Central Nervous System Relapse in Two Patients with Chronic Myelogenous Leukemia in Myeloid Blastic Phase on Imatinib Mesylate Therapy [DOI]
- 16 Isolated CNS relapse of CML after bone marrow transplantation [DOI]
- 17 Pathology of leukemia in the brain and meninges: postmortem studies of patients with acute leukemia and of mice given inoculations of L1210 leukemia.
- 18 Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate [DOI]
- 19 Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhood [DOI]
- 20 Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission [DOI]
- 21 Isolated central nervous system blast crisis in chronic myeloid leukemia
- 22 Central nervous system (CNS) leukemia after imatinib mesylate therapy for chronic myelogenous leukemia (CML) [DOI]
Cited by 4
Heejeong Yoon, Joo H. Kang, Seung Woo Cho · Advanced Healthcare Materials · 2024
Jhansi Rani Arumugam, B.k. Bommannan Karthik, Jayachandran Perumal Kalaiyarasi · Indian Journal of Medical and Paediatric Oncology · 2020
Showing 2 of 4 known citations — external sources report more than can currently be individually listed.
Article metrics
Real usage data collected on this platform.
33
Page views
0
PDF downloads
3
Outbound clicks
4
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.